Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now

Valiant Laboratories IPO opens: key details and expert opinions

Published Sep 27, 2023 03:07AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.

Valiant Laboratories, an India-based pharmaceutical company, opened its initial public offering (IPO) for subscription on Wednesday. The IPO, valued at ₹152.46 crores, will remain open until October 3rd.

The firm, specializing in the manufacturing of Paracetamol as an Active Pharmaceutical Ingredient (API), owns a manufacturing facility in Maharashtra, equipped with an internal research and development (R&D) infrastructure. The R&D facility is furnished with an analytical laboratory and infrastructure for product development activities.

The IPO comprises a fresh issue of 10,890,000 equity shares, with no offer for sale component. The price band for the IPO has been fixed at ₹133 to ₹140 per equity share. Investors can place bids for a minimum of 105 equity shares, and in multiples of 105 equity shares thereafter.

The allocation of shares for the public issue is as follows: not more than 50% for qualified institutional buyers (QIB), not less than 15% for non-institutional investors (NII), and not less than 35% for retail investors.

Valiant Laboratories plans to utilize the net proceeds from the IPO to fund its objectives. These include investment in Valiant Advanced Sciences Private Limited (VASPL), funding working capital requirements, and meeting general corporate purposes.

The company's listed peers include Granules India Ltd, Jagsonpal Pharmaceuticals Ltd, Alkyl Amines Chemicals Ltd, and Laxmi Organic Industries Ltd. Unistone Capital Private Ltd is serving as the book-running lead manager for the Valiant IPO, while Link Intime India Private Ltd is the registrar.

However, the grey market premium (GMP) for Valiant Laboratories shares is currently zero, indicating no premium or discount on the shares in the grey market.

Despite this new opportunity to invest in Valiant Laboratories, experts' opinions on the IPO are not overwhelmingly positive. Dilip Davda, contributing editor at Chittorgarh.com, noted that the company’s financials, such as PAT and RoCE margins, have been on a declining trend. He suggested that based on FY23 earnings, the issue appears to be fully priced, and investors may consider long-term investments for potential rewards.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Valiant Laboratories IPO opens: key details and expert opinions
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email